Curette lavage fluid analysis of EGFR, KRAS, and P53 mutations in lung cancer patients

F. Yamaguchi, K. Fukuchi, S. Tazawa, H. Tateno, E. Kato, A. Wakabayashi, A. Tada, T. Iwasaki, M. Hayashi, Y. Thuchiya, J. Yamashita, N. Takeda, S. Tomita, F. Kokubu (Yokohama, Tokyo, Japan)

Source: Annual Congress 2011 - Progress in endoscopy for the diagnosis of lung cancer
Session: Progress in endoscopy for the diagnosis of lung cancer
Session type: Poster Discussion
Number: 1976
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Yamaguchi, K. Fukuchi, S. Tazawa, H. Tateno, E. Kato, A. Wakabayashi, A. Tada, T. Iwasaki, M. Hayashi, Y. Thuchiya, J. Yamashita, N. Takeda, S. Tomita, F. Kokubu (Yokohama, Tokyo, Japan). Curette lavage fluid analysis of EGFR, KRAS, and P53 mutations in lung cancer patients. Eur Respir J 2011; 38: Suppl. 55, 1976

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Micro-RNA in bronchial lavage of lung cancer patients – First feasibility study
Source: Annual Congress 2010 - New insights in the pathology of lung cancer
Year: 2010


What surgery for which bronchiolo-alveolar carcinoma?
Source: Annual Congress 2006 - Bronchiolo-alveolar carcinoma
Year: 2006


Bacteriologic colonization of the bronchial tree in patients with non small lung carcinoma – Bronchoscopic study
Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series
Year: 2010

Evaluation of IL-10 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013

Detection of lung cancer on CXR – A comparison of radiologist‘s performance
Source: Annual Congress 2010 - Quality management for lung cancer patients
Year: 2010


LungPoint® – A new approach to peripheral lung lesions
Source: Annual Congress 2010 - Tissue is mostly the issue: diagnostic and therapeutic bronchoscopy
Year: 2010


The diagnostic value of bronchoalvolar lavage (BAL) in the diagnosis of peripheral lung cancer (PLC)
Source: Eur Respir J 2003; 22: Suppl. 45, 253s
Year: 2003

Immunocytological study of bronchioloalveolar lavage (BAL) in interstitial lung diseases (ILD) diagnosis
Source: International Congress 2018 – Bronchoscopy and transthoracic ultrasound
Year: 2018


Matrix metalloproteinase-9 (MMP-9) elevated in serum, but not in bronchial lavage in lung cancer patients
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013

Postoperative predicting value of lung function in patients with lung cancer – Fortune-telling or reality? Evaluation after surgical treatment
Source: Annual Congress 2011 - Lung function today and tomorrow II
Year: 2011

Flow cytometry (FC) in examination of broncholaveolar lavage (BAL) in interstitial lung diseases (ILD). Presentation of 14 years‘ experience
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007


Cytotoxic phenotype of alveolar lymphocytes (AL) in bronchoalveolar lavage fluid (BALF) from non-small cell lung cancer (NSCLC) patients
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014

The value of bacterial culture in patients with suspected lung cancer evaluated by bronchoscopy: A prospective study of 155 patients
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014

Bronchoscopy - any use for follow-up of operated lung cancer (LC) patients?
Source: Eur Respir J 2001; 18: Suppl. 33, 17s
Year: 2001

A retrospective study on flexible bronchoscopic yield in the diagnosis of lung cancer – is it operator dependent?
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009


Evaluation of IL-33 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014

Induced sputum (IS) in patients with interstitial lung disease (ILD) – comparison with bronchoalveolar lavage (BAL)
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007


TNF-alpha, IL-1 and IL-6 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC)
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013

Alvolar lymphocytes (AL) in patients with non-small cell lung cancer (NSCLC). Data from tumor-affected lobe
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

The level of bronchoalveolar lavage fluid prostaglandine E2; Is it diagnostic of bronchogenic carcinoma?
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013